DK1638971T3 - Fremstilling af substitueret Quinoxaliner fra dianilinen med 2,3-dihydroxy-1,4-dioxan - Google Patents

Fremstilling af substitueret Quinoxaliner fra dianilinen med 2,3-dihydroxy-1,4-dioxan

Info

Publication number
DK1638971T3
DK1638971T3 DK04734570T DK04734570T DK1638971T3 DK 1638971 T3 DK1638971 T3 DK 1638971T3 DK 04734570 T DK04734570 T DK 04734570T DK 04734570 T DK04734570 T DK 04734570T DK 1638971 T3 DK1638971 T3 DK 1638971T3
Authority
DK
Denmark
Prior art keywords
quinoxalins
dianiline
dihydroxy
dioxane
substituted
Prior art date
Application number
DK04734570T
Other languages
Danish (da)
English (en)
Inventor
Joseph Philip Rainville
Geraldine Patricia Taber
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33511699&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1638971(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DK1638971T3 publication Critical patent/DK1638971T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK04734570T 2003-06-04 2004-05-24 Fremstilling af substitueret Quinoxaliner fra dianilinen med 2,3-dihydroxy-1,4-dioxan DK1638971T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47558903P 2003-06-04 2003-06-04
PCT/IB2004/001787 WO2004108725A1 (en) 2003-06-04 2004-05-24 Preparation of substituted quinoxalines from the dianline with 2,3-dihydroxy-1,4-dioxane

Publications (1)

Publication Number Publication Date
DK1638971T3 true DK1638971T3 (da) 2008-10-27

Family

ID=33511699

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04734570T DK1638971T3 (da) 2003-06-04 2004-05-24 Fremstilling af substitueret Quinoxaliner fra dianilinen med 2,3-dihydroxy-1,4-dioxan

Country Status (17)

Country Link
US (1) US20070185327A1 (de)
EP (1) EP1638971B1 (de)
JP (1) JP2006526607A (de)
AR (1) AR044472A1 (de)
AT (1) ATE405566T1 (de)
BR (1) BRPI0410613A (de)
CA (1) CA2527337A1 (de)
CL (1) CL2004001271A1 (de)
DE (1) DE602004015986D1 (de)
DK (1) DK1638971T3 (de)
ES (1) ES2310730T3 (de)
MX (1) MXPA05013084A (de)
PL (2) PL378491A1 (de)
PT (1) PT1638971E (de)
SI (1) SI1638971T1 (de)
TW (1) TWI251594B (de)
WO (1) WO2004108725A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080275051A1 (en) * 2005-02-24 2008-11-06 Busch Frank R Preparation of High Purity Substituted Quinoxalines
CA2709774C (en) 2008-05-22 2012-10-02 Teva Pharmaceutical Industries Ltd. Varenicline tosylate, an intermediate in the preparation process of varenicline l-tartrate
US20090318695A1 (en) * 2008-06-19 2009-12-24 Vinod Kumar Kansal Processes for the preparation of varenicline and intermediates thereof
WO2010023561A1 (en) * 2008-09-01 2010-03-04 Actavis Group Ptc Ehf Process for preparing varenicline, varenicline intermediates, and pharmaceutically acceptable salts thereof
EP2438054A1 (de) 2009-06-22 2012-04-11 Teva Pharmaceutical Industries Ltd. Festkörperformen von vareniclinsalzen und herstellungsverfahren dafür
CA2791460A1 (en) 2010-03-09 2011-09-15 Actavis Group Ptc Ehf Highly pure varenicline or a pharmaceutically acceptable salt thereof substantially free of methylvarenicline impurity
US20120004239A1 (en) 2010-06-11 2012-01-05 Medichem, S.A. Process for Preparing Quinoxaline Derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2301210T5 (es) * 1997-12-31 2015-05-07 Pfizer Products Inc. Compuestos azapolicíclicos condensados con un arilo
US6605610B1 (en) * 1997-12-31 2003-08-12 Pfizer Inc Aryl fused azapolycyclic compounds
IL157881A0 (en) * 2001-04-20 2004-03-28 Pfizer Prod Inc Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds

Also Published As

Publication number Publication date
MXPA05013084A (es) 2006-03-02
EP1638971B1 (de) 2008-08-20
EP1638971A1 (de) 2006-03-29
DE602004015986D1 (de) 2008-10-02
ATE405566T1 (de) 2008-09-15
TWI251594B (en) 2006-03-21
WO2004108725A1 (en) 2004-12-16
PT1638971E (pt) 2008-10-23
SI1638971T1 (sl) 2008-12-31
ES2310730T3 (es) 2009-01-16
TW200500365A (en) 2005-01-01
PL1638971T3 (pl) 2009-01-30
CA2527337A1 (en) 2004-12-16
JP2006526607A (ja) 2006-11-24
BRPI0410613A (pt) 2006-06-20
PL378491A1 (pl) 2006-05-02
US20070185327A1 (en) 2007-08-09
AR044472A1 (es) 2005-09-14
CL2004001271A1 (es) 2005-04-22

Similar Documents

Publication Publication Date Title
DK1620437T3 (da) 5,7-diaminopyrazolo-4,3-d-pyrimidiner, der er anvendelige til behandling af hypertension
FR2857406B1 (fr) Refroidissement des anneaux de turbine
DK1622880T3 (da) Substituerede dihydroquinazoliner med antivirale egenskaber
DK1828164T3 (da) Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider
DK1858917T3 (da) Varicella-zoster-virus-vaccine
DE602004006169D1 (de) Substituierte 8'-pyri(mi)dinyl-dihydrospiro-äcycloalkylaminü-pyrimidoä1,2aüpyrimidin-6-onderivate
DK1934327T3 (da) Mikroorganismer, der hæmmer dannelsen af armhulelugt
DK1756049T3 (da) Fremgangsmåde til fremstilling af 1,4-diphenylazetidinon-derivater
DK1861389T3 (da) 7-(2-(4-(3-triflourmethylphenyl)-1,2,3,6-tetrahydro-pyrid-1-yl)ethyl)isoquinoleinbesylatsalt
DE602004024770D1 (de) Substituierte 8-perfluoro-6,7,8,9-tetrahydropyrimido-(1,2a) pyrimidin-4-on derivate
DK1846376T3 (da) Fremgangsmåde til fremstilling af 10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepin-5-carboxamid
ATE517878T1 (de) Substituierte 5-phenyl-3,6-dihydro-2-oxo-6h-ä1,3, 4üthiadiazine
DK1682542T3 (da) Nyt krystallinsk anhydrat med anticholinerg effekt
AP2005003370A0 (en) Novel crystalline modification of the anhydrate ofboscalid.
DK1667967T3 (da) Fremgangsmåde til fremstilling af 2-oxo-1-pyrrolidin-derivater
DK1831223T3 (da) Fremgangsmåde til fremstilling af L-biopterin
DK1838683T3 (da) Fremgangsmåde til fremstilling af [1,4,5]-oxadiazepinderivater
DK1638971T3 (da) Fremstilling af substitueret Quinoxaliner fra dianilinen med 2,3-dihydroxy-1,4-dioxan
DK1678135T3 (da) Fremgangsm de til fremstilling af n-amino-substituerede hetorocykliske forbindelser
DK1656365T3 (da) Fremgangsmåde til fremstilling af enantiomerisk rent mirtazapin
DK1660485T3 (da) Forbedret fremgangsmåde til fremstilling af alpha-polymorfisk eletriptanhydrobromid
ITMI20032432A1 (it) Pentola
DK1511724T3 (da) Fremgangsmåde til fremstilling af thioalkylaminderivater
DK1786913T3 (da) Fremgangsmåde til fremstilling af diarylcycloalkylderivater
DK1692105T3 (da) Fremgangsmåde til fremstilling af (3-oxo-2,3-dihydro-1H-isoindol-1-yl)-acetylguanidin-derivater